Therapeutic potential of the LXA4-ALX/FPR2 axis in osteoarthritis

LXA4-ALX/FPR2轴在骨关节炎中的治疗潜力

• 批准号: 450992
• 负责人: Fahmi Hassan
• 金额: $ 61.3万
• 依托单位: Centre hospitalier de l'Universit de Montral (CHUM)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2026-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=450992&lang=en
• 关键词: 15-Lipoxygenase; Alx/Fpr2; Cartilage; Gene Expression; Lipoxin A4 (Lxa4); Osteoarthritis

Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability in Canada and worldwide. It has a large impact on the patient's quality of life, and constitutes a significant socioeconomic burden. There is currently no effective

骨关节炎（OA）是最常见的关节炎形式，也是加拿大和全球残疾的主要原因。它对患者的生活质量有很大的影响，并构成了重大的社会经济负担。目前尚无有效